Abstract
Given the important role of the estrogen receptor (ER) in the development and physiology of the breast, it is essential to delineate the mechanisms responsible for its failed expression in some breast tumors. We have cloned and sequenced a portion of the ER upstream regulatory region from the ER-positive MCF-7 and the ER-negative MDA-MB-231 breast cancer cell lines to determine if sequence alterations in this region account for the ER-negative phenotype of some tumors. From this, we identified a number of variations between the sequences, two of which were determined to be associated with a 50% decrease in CAT activity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 131-139 |
| Number of pages | 9 |
| Journal | Cancer Letters |
| Volume | 113 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - Feb 26 1997 |
Bibliographical note
Funding Information:This work was supportedb y a grant BE-72794 from the American Cancer Society to SMH.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Breast cancer
- Estrogen receptor
- Gene expression
Fingerprint
Dive into the research topics of 'Identification of sequence alterations in the upstream regulatory region of the estrogen receptor gene in an ER-negative breast cancer cell line'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS